DNAPrint Genomics, Inc.
DNAG
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | 09/30/2006 | |
|---|---|---|---|---|---|
| Net Income | -10.86% | -158.76% | 174.81% | -15.60% | -40.45% |
| Total Depreciation and Amortization | -2.15% | 2.12% | 0.46% | 4.79% | 3.38% |
| Total Amortization of Deferred Charges | -100.00% | -47.75% | -5.21% | -22.85% | -17.74% |
| Total Other Non-Cash Items | 26.24% | 109.06% | -297.85% | 332.18% | -17.27% |
| Change in Net Operating Assets | -90.64% | 15.21% | -104.97% | -14.47% | 363.02% |
| Cash from Operations | -12.73% | 3.10% | -284.28% | 73.85% | 41.77% |
| Capital Expenditure | -- | 100.00% | 98.76% | -84.25% | -101.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.64% | 2.83% | 251.77% | -- | -- |
| Cash from Investing | -32.73% | 2.93% | 395.65% | 548.86% | -101.84% |
| Total Debt Issued | -- | -- | -- | 191.35% | -94.00% |
| Total Debt Repaid | 53.68% | 56.46% | -287.72% | -9.59% | 39.70% |
| Issuance of Common Stock | -- | -75.27% | 94.61% | 0.19% | -45.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 39.84% | 45.37% | -353.68% | 292.83% | -96.41% |
| Foreign Exchange rate Adjustments | -1,075.00% | 200.00% | -91.67% | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -256.58% | 173.35% | -167.22% | 139.50% | -275.92% |